Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer

1 Jan 2016

Abstract excerpt

The critical point for successful treatment of cancer is diagnosis at early stages of tumor development. Cancer cell-specific methylated DNA has been found in the blood of cancer patients, indicating that cell-free DNA (cfDNA) circulating in the blood is a convenient tumor-associated DNA marker. Therefore methylated cfDNA can be used as a minimally invasive diagnostic marker. We analysed the concentration of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27725787
DOI: 10.1155/2016/3693096

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal CancerPMID 27725787Read ↗

Cell-free DNA as a diagnostic marker for cancer: current insightsSemantic proximity Read ↗

Cell-free DNA for the detection of pancreatic, liver and upper gastrointestinal cancers: has progress been made?Semantic proximity Read ↗

Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinomaSemantic proximity Read ↗

Circulating cell-free DNA: A promising marker of regional lymphonode metastasis in breast cancer patientsSemantic proximity Read ↗

Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers’ DiscoverySemantic proximity Read ↗

Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq)Semantic proximity Read ↗

Quantitative measurement of cell-free plasma DNA and applications for detecting tumor genetic variation and promoter methylation in a clinical setting.Semantic proximity Read ↗

Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control studySemantic proximity Read ↗

Discovery and Validation of Methylation Signatures in Circulating Cell-Free DNA for the Detection of Colorectal CancerSemantic proximity Read ↗

Detection of Colorectal Cancer in Circulating Cell-Free DNA by Methylated CpG Tandem Amplification and SequencingSemantic proximity Read ↗

DNA methylation signatures in circulating cell-free DNA as biomarkers for the early detection of cancerSemantic proximity Read ↗

DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.